(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.58%) $78.56
(0.65%) $2.16
(-0.16%) $2 304.80
(1.21%) $27.01
(-0.36%) $961.80
(-0.04%) $0.928
(-0.22%) $10.85
(-0.07%) $0.796
(0.00%) $91.45
Live Chart Being Loaded With Signals
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy...
Stats | |
---|---|
今日成交量 | 177 500 |
平均成交量 | 264 810 |
市值 | 29.21B |
EPS | ¥0 ( 2024-03-12 ) |
下一个收益日期 | ( ¥0 ) 2024-06-11 |
Last Dividend | ¥0 ( N/A ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 144.82 |
ATR14 | ¥0.592 (0.12%) |
音量 相关性
StemRIM 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
StemRIM 相关性 - 货币/商品
StemRIM 财务报表
Annual | 2023 |
营收: | ¥2.35B |
毛利润: | ¥2.30B (97.97 %) |
EPS: | ¥2.80 |
FY | 2023 |
营收: | ¥2.35B |
毛利润: | ¥2.30B (97.97 %) |
EPS: | ¥2.80 |
FY | 2022 |
营收: | ¥22.98M |
毛利润: | ¥22.98M (100.00 %) |
EPS: | ¥-32.92 |
FY | 2021 |
营收: | ¥1.40B |
毛利润: | ¥0.00 (0.00 %) |
EPS: | ¥-10.78 |
Financial Reports:
No articles found.
StemRIM
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。